NCT00990613
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +17 more
- Locations
-
- Pfizer Investigational Site Kalamazoo, Michigan, United States
Clinical trial condition
Chorea
Explore clinical trials studying Chorea. Study availability and eligibility vary by location and protocol.
209 public trials
39 recruiting studies
Chorea trial results
NCT00988624
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +16 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +24 more
- Locations
-
- Pfizer Investigational Site Miami, Florida, United States
- Pfizer Investigational Site Saint Paul, Minnesota, United States
NCT00931073
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +17 more
- Locations
-
- Pfizer Investigational Site Kalamazoo, Michigan, United States
NCT00831506
- Conditions
- Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +15 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
Completed
A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan
NCT00788047
- Conditions
- Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +15 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
NCT00075140
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- The University of Iowa College of Nursing Iowa City, Iowa, United States
Completed
Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease
NCT00095355
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
NCT00387270
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- Huntington Study Group Rochester, New York, United States
Completed
TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
NCT00146211
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +23 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- University of California San Diego La Jolla, California, United States
- UCLA Medical Center Los Angeles, California, United States